Skip to content
MedsAcross

Medicine

Hydrocortisone, Neomycin and Polymyxin b 10 mg/3.5 mg/10000 IU per mL ear drops

Available on requestPrescription onlyUS FDAGeneric name

Hydrocortisone, Neomycin and Polymyxin b 10 mg/3.5 mg/10000 IU per mL ear drops is a generic prescription medicine for otic use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 15° to 25°C (59° to 77°F).

Key facts

Active ingredient (INN)
Hydrocortisone, Neomycin and Polymyxin b
Brand
Sold under the generic name
Strength
10 mg/3.5 mg/10000 IU per mL
Dosage form
Ear drops
Route
Otic
Packs
1 bottle
Manufacturers
Orbicular Pharmaceutical TechnologiesIndiaHikma Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 15° to 25°C (59° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
8 October 2026
Identifiers
RxCUI 204423DailyMed set ID 5eae31aa-ec63-4b93-9859-8d718a8ac8ef, 2846b507-f92d-45e0-9807-f68bdf4de56cNDC 81607-014, 0054-0975Application ANDA220938

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper81607-014-10Orbicular Pharmaceutical TechnologiesIndia8 October 2026
1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper0054-0975-80Hikma Pharmaceuticals8 October 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 16 April 1963Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Hydrocortisone, Neomycin and Polymyxin b

Clinical summary

Hydrocortisone, Neomycin and Polymyxin b is a fixed-dose combination of an aminoglycoside antibacterial, a corticosteroid and a polymyxin-class antibacterial. It is available as otic suspension, ear drops and otic solution for ophthalmic use. MedsAcross supplies Hydrocortisone, Neomycin and Polymyxin b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Hydrocortisone, Neomycin and Polymyxin b

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Need Hydrocortisone, Neomycin and Polymyxin b 10 mg/3.5 mg/10000 IU per mL ear drops for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.